Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measurement of the Distribution of Optical Properties in Adult Human Muscle

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by University of California, Irvine
Sponsor:
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00540683
First received: October 4, 2007
Last updated: February 5, 2016
Last verified: February 2016

October 4, 2007
February 5, 2016
October 2004
July 2018   (final data collection date for primary outcome measure)
Healthy Muscle [ Time Frame: upto 4 weeks ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00540683 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Measurement of the Distribution of Optical Properties in Adult Human Muscle
Measurement of the Distribution of Optical Properties in Adult Human Muscle
The researcher can use Diffuse Optical spectroscopy technique that uses harmless levels of near-infrared light to probe the concentrations and states of important physiological molecules such as hemoglobin water and lipids in human muscle,.

The researcher can monitor muscle physiology, for example during exercise or in response to external factors such as shock by Diffuse Optical spectroscopy technique.

The Diffuse Optical spectroscopy technique can determine significant changes in muscle, muscle structure, muscle tissues metabolism and hemodynamics.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Study population will be selected from outpatient clinic at University Of California Irvine, and staffs and students.
Muscle Disorder
Device: Diffuse Optical Spectroscopy
Muscle properties
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
140
July 2018
July 2018   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male or Female age 18 years and older
  • Diagnosed of Cachexic condition
  • Diagnosed of Cellulite adult female 18 years and older

Exclusion Criteria:

  • Pregnant women
  • Taking light sensitive drugs for use in photodynamic therapy
Both
18 Years to 75 Years   (Adult, Senior)
Yes
Contact: Montana Compton, R.N 949-824-9265 mocomton@uci.edu
United States
 
NCT00540683
NIH/LAMMP-2004-3626
No
Not Provided
Not Provided
Beckman Laser Institute and Medical Center, University of California, Irvine
University of California, Irvine
Beckman Laser Institute University of California Irvine
Principal Investigator: Bruce Tromberg, Ph.D Beckman Laser Institute University of California Irvine
University of California, Irvine
February 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP